Previous 10 | Next 10 |
BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced new, patented ransomware prevention technology that delivers end-to-end ransomware coverage to anticipate advanced attacks as well as accelerate det...
Royalty Receipts growth of 14% driving Portfolio Receipts of $717 million Net cash provided by operating activities of $665 million Full year 2024 guidance confirmed: Portfolio Receipts expected to be $2,600 to $2,700 million Commitment to grow dividend by mid-single d...
Frexalimab is in Phase 3 development by Sanofi in multiple sclerosis with multi-blockbuster potential in a wide range of immune-mediated diseases Expands Royalty Pharma’s development-stage portfolio to 15 therapies with the combined potential to generate significantly greater tha...
A look at the top 10 most actives in the United States iSun Inc. (ISUN) rose 51.4% to $0.1998 on volume of 132,838,583 shares Reborn Coffee Inc. (REBN) rose 84.4% to $3.19 on volume of 109,626,591 shares PROSHARES TRUST (SQQQ) rose 0.2% to $10.74 on volume of 99,444,834 shares Nikola Co...
A look at the top 10 most actives in the United States iSun Inc. (ISUN) rose 39.1% to $0.1836 on volume of 68,543,172 shares Reborn Coffee Inc. (REBN) rose 122.5% to $3.85 on volume of 42,107,040 shares Pineapple Energy Inc. (PEGY) rose 6.9% to $0.0809 on volume of 28,629,136 shares Nik...
2024-05-08 09:01:24 ET "RPD’s mis-execution/misjudgment on converting VM base of customers into Cloud Risk Complete, along with plans to develop and present an improved offering this summer to galvanize adoption, have introduced incremental risk to topline outlook," said Citi analyst...
2024-05-08 00:50:07 ET Rapid7 Inc. (RPD) Q1 2024 Earnings Conference Call May 07, 2024, 04:30 PM ET Company Participants Elizabeth Chwalk - Director of Investor Relations Corey Thomas - Chairman & Chief Executive Officer Timothy Adams - Chief Financial Office...
2024-05-07 17:09:13 ET More on Rapid7 Rapid7: Positive Profitability Improvements, Stock Appears Fully Valued Rapid7 Inc. (RPD) Q4 2023 Earnings Call Transcript Rapid7 dips after revenue outlook falls short of market expectations Rapid7 Q1 2024 Earnings Previ...
2024-05-07 16:42:14 ET More on Rapid7 Rapid7: Positive Profitability Improvements, Stock Appears Fully Valued Rapid7 Inc. (RPD) Q4 2023 Earnings Call Transcript Rapid7 Q1 2024 Earnings Preview Seeking Alpha’s Quant Rating on Rapid7 Historical e...
Annualized recurring revenue (“ARR”) of $807 million, an increase of 11% year-over-year Total revenue of $205 million, up 12% year-over-year; Product subscriptions revenue of $197 million, up 13% year-over-year GAAP operating income of $11 million; Non-GAAP operating income ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2024 financial results on Thursday, August 8, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 ...
NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2024 of $0.21 per Class A ordinary share. The dividend will be paid on September 13, 2024, to shareholders of record at the...
2024-07-09 22:15:01 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for RPD on July 9, 2024 09:06PM ET. The previous analyst recommendation was Equal-Weight. RPD was trading at $39.72 at issue of the analyst recommendation. The overall analyst consensus : BU...